NASDAQ:ARDS
Aridis Pharmaceuticals Inc. Stock News
$0.0615
+0.0025 (+4.24%)
At Close: May 03, 2024
Aridis (ARDS) Up on Receiving FDA's QIDP Designation for AR-301
11:51am, Thursday, 13'th Jul 2023
Aridis (ARDS) achieves a milestone as the FDA granted the Qualified Infectious Disease Product designation for AR-301.
Aridis (ARDS) Up on Regulatory Update for Pneumonia Drug
12:34pm, Wednesday, 21'st Jun 2023
Aridis (ARDS) announces that its AR-301 clinical program is eligible for availing the FDA's special pathway for satisfying the unmet medical need of a predefined limited population.
Aridis (ARDS) Up After FDA Nod for Pneumonia Drug Study Design
12:36pm, Thursday, 01'st Jun 2023
Aridis (ARDS) stock jumps 115% after the company reports reaching an agreement with the FDA on its proposed study on AR-301 as an adjunctive treatment for hospital-acquired pneumonia.
Utilizing Fundamental Analysis for Your Penny Stocks? 3 Tips
06:00am, Thursday, 01'st Jun 2023
Penny stocks, often defined as shares trading for less than $5, present a unique opportunity for investors seeking high potential returns. Despite their low market price, these stocks can offer signif
5 Hot Penny Stocks To Watch With Big News This Week
11:16am, Wednesday, 31'st May 2023
Whether you're trading penny stocks or higher-priced company shares, everyone wants to gain an edge. In the stock market today, there are plenty of catalysts to consider.
Aridis (ARDS) Stock Up as Cystic Fibrosis Study Meets Goals
01:44pm, Tuesday, 14'th Mar 2023
Aridis Pharmaceuticals (ADRS) meets primary and secondary endpoints in a phase IIa study on AR-501 for treating cystic fibrosis.
Aridis Pharmaceuticals (ARDS) Reports Q3 Loss, Misses Revenue Estimates
09:04pm, Monday, 21'st Nov 2022
Aridis Pharmaceuticals (ARDS) delivered earnings and revenue surprises of -4,100% and 96.44%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the s
Aridis Pharmaceuticals (ARDS) Reports Q2 Loss, Misses Revenue Estimates
06:48pm, Tuesday, 16'th Aug 2022
Aridis Pharmaceuticals (ARDS) delivered earnings and revenue surprises of -650% and 97.21%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Here's Why Aridis Pharmaceuticals (ARDS) Looks Ripe for Bottom Fishing
11:31am, Friday, 01'st Jul 2022
Aridis Pharmaceuticals (ARDS) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreeme
Aridis Pharmaceuticals (ARDS) Reports Q1 Loss, Lags Revenue Estimates
06:48pm, Monday, 16'th May 2022
Aridis Pharmaceuticals (ARDS) delivered earnings and revenue surprises of 13.73% and 40.65%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Aridis Pharma COVID-19 Antibody Neutralizes Omicron Variant In Animal Study
04:41pm, Thursday, 17'th Feb 2022 Benzinga
Aridis Pharmaceuticals Inc''s (NASDAQ: ARDS ) fully human monoclonal antibodies (mAbs) in the AR-701 cocktail has been shown to neutralize the SARS-CoV-2 omicron variant . Both mAbs conferred complete protection against Omicron infected animals when given either parenterally or by intranasal administration. Both mAbs in the AR-701 cocktail, i.e., AR-720 and AR-703, … Full story available on Benzinga.com
Aridis, Rhythm top healthcare gainers; 10x Genomics, iSpecimen lead losers pack
03:05pm, Thursday, 17'th Feb 2022 Seeking Alpha
Aridis Pharmaceuticals ARDS +12%. Rhythm Pharmaceuticals RYTM +12%. 10x Genomics (TXG) -16%. iSpecimen ISPC -10%.
Short Squeeze Stocks: ARDS, BBIG and 3 Others Experts Think Are Ready to Pop
02:41pm, Monday, 14'th Feb 2022
As far as short squeeze stocks go, these five companies top the list in terms of both short interest and borrow fee rates right now. The post Short Squeeze Stocks: ARDS, BBIG and 3 Others Experts Thin
5 Short Squeeze Candidate To Watch: Aridis Pharmaceuticals Tops List, EVgo, Indonesia Energy Corp And More
10:40am, Monday, 14'th Feb 2022
Potential short squeeze plays gained steam in 2021, with new retail traders looking for the next huge move. A short squeeze can occur when a heavily shorted stock rises in value instead of falling.
4 Short Squeeze Penny Stocks To Buy For Under $5 Right Now
08:11am, Friday, 11'th Feb 2022
Are these short squeeze penny stocks on our watch list right now? The post 4 Short Squeeze Penny Stocks To Buy For Under $5 Right Now appeared first on Penny Stocks to Buy, Picks, News and Information